LawsuitSettlement

Judge Approves $600 Million Botox Settlement

A federal investigation into Allergan's misleading marketing of its wrinkle-smoothing Botox medication is over after a judge in Georgia on Tuesday approved the pharmaceutical firm's decision to pay $600 million and plead guilty to misbranding the product.